![]() | |
Clinical data | |
---|---|
Pronunciation | /kloʊˈbeɪtəsɒl/[1] |
Trade names | Temovate, Clobex, others |
AHFS/Drugs.com | Monograph |
License data | |
Routes of administration | Topical only |
Drug class | Corticosteroid[2] |
Legal status | |
Legal status |
|
Identifiers | |
| |
Chemical and physical data | |
Formula | C25H32ClFO5 |
Molar mass | 466.97 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Clobetasol propionate is a corticosteroid used to treat skin conditions such as eczema, contact dermatitis, seborrheic dermatitis, and psoriasis.[2] It is applied to the skin as a cream, ointment, or shampoo.[2][4] Use should be short term and only if other weaker corticosteroids are not effective.[4] Use is not recommended in rosacea or perioral dermatitis.[2]
Common side effects include skin irritation, dry skin, redness, pimples, and telangiectasia.[2] Serious side effects may include adrenal suppression, allergic reactions, cellulitis, and Cushing's syndrome.[2] Use in pregnancy and breastfeeding is of unclear safety.[5] Clobetasol is believed to work by activating steroid receptors.[2] It is a US class I (Europe: class IV) corticosteroid, making it one of the strongest available.[6]
Clobetasol propionate was patented in 1968 and came into medical use in 1978.[7] It is available as a generic medication.[4] A month supply in the United Kingdom costs the NHS about 7.90 £ as of 2019.[4] In the United States the wholesale cost of this amount is about US$66.[8] In 2017, it was the 209th most commonly prescribed medication in the United States, with more than two million prescriptions.[9][10]
References
edit- ^ "Clobetasol Propionate Topical Ointment 0.05% Information – Drug Encyclopedia". Kaiser Permanente. Archived from the original on 2021-08-28. Retrieved 2009-10-09.
- ^ a b c d e f g h i "Clobetasol Propionate Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Archived from the original on 28 August 2021. Retrieved 13 April 2019.
- ^ Cite error: The named reference
who
was invoked but never defined (see the help page). - ^ a b c d British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 1210. ISBN 9780857113382.
- ^ "Clobetasol topical Use During Pregnancy". Drugs.com. Archived from the original on 28 August 2021. Retrieved 13 April 2019.
- ^ Ference, JD; Last, AR (15 January 2009). "Choosing topical corticosteroids". American family physician. 79 (2): 135–40. PMID 19178066.
- ^ Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 487. ISBN 9783527607495. Archived from the original on 2019-02-28. Retrieved 2019-03-01.
- ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Archived from the original on 2019-03-06. Retrieved 3 March 2019.
- ^ "The Top 300 of 2020". ClinCalc. Archived from the original on 12 February 2021. Retrieved 11 April 2020.
- ^ "Clobetasol Propionate - Drug Usage Statistics". ClinCalc. Archived from the original on 12 April 2020. Retrieved 11 April 2020.